Dr. Pavan Chava, DO
NPI: 1154511079
Total Payments
$70,128
2023 Payments
$32.77
Companies
10
Transactions
96
Medicare Patients
1,200
Medicare Billing
$88,570
Payment Breakdown by Category
Other$58,126 (82.9%)
Travel$4,292 (6.1%)
Consulting$3,709 (5.3%)
Food & Beverage$2,822 (4.0%)
Research$1,173 (1.7%)
Education$6.02 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $58,126 | 28 | 82.9% |
| Travel and Lodging | $4,292 | 20 | 6.1% |
| Consulting Fee | $3,709 | 5 | 5.3% |
| Food and Beverage | $2,822 | 40 | 4.0% |
| Unspecified | $1,173 | 2 | 1.7% |
| Education | $6.02 | 1 | 0.0% |
Payments by Type
General
$68,955
94 transactions
Research
$1,173
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $37,665 | 33 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $25,161 | 40 | $0 (2019) |
| PFIZER INC. | $4,176 | 7 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $2,628 | 7 | $0 (2018) |
| Medtronic MiniMed, Inc. | $216.07 | 3 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $105.58 | 1 | $0 (2017) |
| Becton, Dickinson and Company | $104.66 | 1 | $0 (2017) |
| Alexion Pharmaceuticals, Inc. | $32.77 | 1 | $0 (2023) |
| Mallinckrodt LLC | $22.65 | 2 | $0 (2017) |
| Tandem Diabetes Care, Inc. | $16.11 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $32.77 | 1 | Alexion Pharmaceuticals, Inc. ($32.77) |
| 2020 | $5,983 | 5 | Novo Nordisk Inc ($5,967) |
| 2019 | $17,620 | 19 | Novo Nordisk Inc ($17,226) |
| 2018 | $19,433 | 26 | Novo Nordisk Inc ($14,472) |
| 2017 | $27,059 | 45 | Janssen Pharmaceuticals, Inc ($22,616) |
All Payment Transactions
96 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/05/2023 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $32.77 | General |
| Category: Rare Disease | ||||||
| 10/05/2020 | Novo Nordisk Inc | RYBELSUS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $289.00 | General |
| Category: Diabetes | ||||||
| 05/01/2020 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,890.00 | General |
| Category: Diabetes | ||||||
| 05/01/2020 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $578.00 | General |
| Category: Diabetes | ||||||
| 03/13/2020 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,210.00 | General |
| Category: Diabetes | ||||||
| 01/27/2020 | Tandem Diabetes Care, Inc. | t:slim X2 insulin pump (Device) | Food and Beverage | Cash or cash equivalent | $16.11 | General |
| Category: Endocrinology | ||||||
| 10/30/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/11/2019 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $867.00 | General |
| 09/17/2019 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,210.00 | General |
| Category: Diabetes | ||||||
| 09/17/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $115.72 | General |
| Category: Diabetes | ||||||
| 09/10/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $9.51 | General |
| Category: Diabetes | ||||||
| 08/29/2019 | Novo Nordisk Inc | Xultophy 100/3.6 (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,210.00 | General |
| Category: Diabetes | ||||||
| 08/29/2019 | Novo Nordisk Inc | Xultophy 100/3.6 (Drug) | Food and Beverage | In-kind items and services | $121.23 | General |
| Category: Diabetes | ||||||
| 07/25/2019 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,975.00 | General |
| 07/25/2019 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $75.40 | General |
| 07/25/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $50.11 | General |
| 06/27/2019 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,210.00 | General |
| Category: Diabetes | ||||||
| 06/27/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $124.79 | General |
| Category: Diabetes | ||||||
| 06/10/2019 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $289.00 | General |
| 03/26/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/02/2019 | Novo Nordisk Inc | Tresiba (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,020.50 | General |
| Category: Diabetes | ||||||
| 03/02/2019 | Novo Nordisk Inc | Tresiba (Drug) | Travel and Lodging | In-kind items and services | $463.14 | General |
| Category: Diabetes | ||||||
| 03/02/2019 | Novo Nordisk Inc | Tresiba (Drug) | Travel and Lodging | In-kind items and services | $343.96 | General |
| Category: Diabetes | ||||||
| 03/02/2019 | Novo Nordisk Inc | Tresiba (Drug) | Travel and Lodging | In-kind items and services | $95.67 | General |
| Category: Diabetes | ||||||
| 03/02/2019 | Novo Nordisk Inc | Tresiba (Drug) | Travel and Lodging | In-kind items and services | $45.15 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Combination rationale ms; Rationale for a fixed-ratio co-formulation of a basal insulin analog and a glucagon-like protein 1 receptor agonist in patients with type 2 diabetes | SANOFI-AVENTIS U.S. LLC | $1,006 | 1 |
| LIX 3514-Basal Unmet Needs | SANOFI-AVENTIS U.S. LLC | $166.80 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 336 | 360 | $90,009 | $23,918 |
| 2022 | 4 | 303 | 367 | $89,067 | $23,890 |
| 2021 | 4 | 272 | 331 | $75,639 | $21,613 |
| 2020 | 3 | 289 | 334 | $81,082 | $19,149 |
Total Patients
1,200
Total Services
1,392
Medicare Billing
$88,570
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 162 | 182 | $43,850 | $12,661 | 28.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $14,740 | $3,859 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 61 | 63 | $14,805 | $3,515 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 40 | $6,592 | $1,806 | 27.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 22 | 22 | $7,942 | $1,533 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 13 | 13 | $2,080 | $543.61 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 155 | 204 | $47,940 | $14,126 | 29.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 72 | 72 | $25,992 | $6,727 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 38 | 42 | $6,720 | $1,715 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 29 | $8,015 | $1,263 | 15.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 11 | 20 | $400.00 | $59.01 | 14.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 129 | 165 | $38,775 | $11,651 | 30.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 54 | 54 | $19,494 | $5,359 | 27.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 45 | 51 | $8,160 | $2,441 | 29.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 26 | $6,350 | $1,705 | 26.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 12 | $2,400 | $394.77 | 16.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 11 | 23 | $460.00 | $61.86 | 13.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 127 | 164 | $39,260 | $9,002 | 22.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 53 | 53 | $19,733 | $5,056 | 25.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 56 | 59 | $9,632 | $2,192 | 22.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 31 | 35 | $8,585 | $1,999 | 23.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 22 | 23 | $3,872 | $900.64 | 23.3% |
About Dr. Pavan Chava, DO
Dr. Pavan Chava, DO is a Student in an Organized Health Care Education/Training Program healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1154511079.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pavan Chava, DO has received a total of $70,128 in payments from pharmaceutical and medical device companies, with $32.77 received in 2023. These payments were reported across 96 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($58,126).
As a Medicare-enrolled provider, Chava has provided services to 1,200 Medicare beneficiaries, totaling 1,392 services with total Medicare billing of $88,570. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine
- Location New Orleans, LA
- Active Since 07/26/2007
- Last Updated 09/29/2009
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1154511079
Products in Payments
- INVOKANA (Drug) $25,125
- Ozempic (Drug) $13,094
- Tresiba (Drug) $8,721
- ADLYXIN (Drug) $2,628
- Xultophy 100/3.6 (Drug) $2,331
- RYBELSUS (Drug) $289.00
- Minimed 670G System (Device) $216.07
- JARDIANCE (Drug) $105.58
- BD Nano (Device) $104.66
- XARELTO (Drug) $35.83
- STRENSIQ (Biological) $32.77
- OFIRMEV (Drug) $22.65
- t:slim X2 insulin pump (Device) $16.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in New Orleans
Dr. Rima El-Abassi, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $255,887
Student in an Organized Health Care Education/Training Program $255,887
Dr. Patrick Greiffenstein, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $214,722
Student in an Organized Health Care Education/Training Program $214,722
Veronica Gillispie, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $126,771
Student in an Organized Health Care Education/Training Program $126,771
Michael Bernard, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $121,414
Student in an Organized Health Care Education/Training Program $121,414
Nicole Lapinel, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $114,205
Student in an Organized Health Care Education/Training Program $114,205
Lingling Du, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $94,740
Student in an Organized Health Care Education/Training Program $94,740